Clinical Trial: Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536802) titled 'Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial' on April 10.

Brief Summary: Primary objective of the study is to evaluate the impact of adenosine pre-medication on incidence of slow flow/no-reflow after primary percutaneous coronary intervention.

Study Start Date: June 01, 2025

Study Type: INTERVENTIONAL

Condition: ST-Segment Elevation Myocardial Infarction (STEMI) No-Reflow Phenomenon Coronary Slow Flow Acute Myocardial Infarction

Intervention: DRUG: Adenosine pre-medication

Patients will receive intracoronary adenosine before primary PCI in addition to standard pharmacolo...